This document provides information to select heart failure patients who would benefit most from the CardioMEMS HF System, along with BNP thresholds.
Note: The CHAMPION trial specifically excluded patients with American College of Cardiology/ American Heart Association stage D heart failure who needed advanced therapies (i.e., left ventricular assist device, transplant or inotropic support). Even if inotropic support improved heart failure symptoms, a patient would still be defined as stage D, with refractory heart failure.2
MAT-2006770 v9.0
Stay Connected